Cogent Biosciences, Inc. COGT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s accounts payable?
- Cogent Biosciences, Inc. (COGT) reported accounts payable of $13.74M in Q1 2026.
- How has Cogent Biosciences, Inc.'s accounts payable changed year-over-year?
- Cogent Biosciences, Inc.'s accounts payable decreased by 2.9% year-over-year, from $14.15M to $13.74M.
- What is the long-term trend for Cogent Biosciences, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s accounts payable has grown at a 67.0% compound annual growth rate (CAGR), from $732K to $9.5M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.